These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39178210)

  • 1. High Cellular Internalization of Virus-Like Mesoporous Silica Nanoparticles Enhances Adaptive Antigen-Specific Immune Responses against Cancer.
    Phan NM; Nguyen TL; Choi Y; Mo XW; Trinh TA; Yi GR; Kim J
    ACS Appl Mater Interfaces; 2024 Sep; 16(35):45917-45928. PubMed ID: 39178210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy.
    Gao Y; Zhang Y; Xia H; Ren Y; Zhang H; Huang S; Li M; Wang Y; Li H; Liu H
    Drug Deliv; 2023 Dec; 30(1):2183814. PubMed ID: 36843529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.
    Goto K; Ueno T; Sakaue S
    J Biosci Bioeng; 2024 Sep; 138(3):254-260. PubMed ID: 38890051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy.
    Liu J; Cui Y; Cabral H; Tong A; Yue Q; Zhao L; Sun X; Mi P
    ACS Nano; 2024 Sep; 18(37):25826-25840. PubMed ID: 39196858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
    Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
    Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
    Dong Y; Gao J; Pei M; Wang X; Zhang C; Du Y; Jiang Y
    Int J Nanomedicine; 2020; 15():2685-2697. PubMed ID: 32368049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells.
    Ma L; Diao L; Peng Z; Jia Y; Xie H; Li B; Ma J; Zhang M; Cheng L; Ding D; Zhang X; Chen H; Mo F; Jiang H; Xu G; Meng F; Zhong Z; Liu M
    Adv Mater; 2021 Oct; 33(43):e2104849. PubMed ID: 34536044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
    Zha Y; Fu L; Liu Z; Lin J; Huang L
    J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin.
    Lee SJ; Kim JJ; Kang KY; Paik MJ; Lee G; Yee ST
    Int J Nanomedicine; 2019; 14():8235-8249. PubMed ID: 31802864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.
    Xi X; Zhang L; Lu G; Gao X; Wei W; Ma G
    J Immunol Res; 2018; 2018():3714960. PubMed ID: 30018987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.
    Kim SY; Noh YW; Kang TH; Kim JE; Kim S; Um SH; Oh DB; Park YM; Lim YT
    Biomaterials; 2017 Jun; 130():56-66. PubMed ID: 28364631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
    Lee JY; Kim MK; Nguyen TL; Kim J
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity.
    Li X; Wang X; Ito A; Tsuji NM
    Nat Commun; 2020 Jul; 11(1):3858. PubMed ID: 32737343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
    Cuzzubbo S; Banissi C; Rouchon MS; Tran T; Tanchot C; Tartour E; Carpentier AF
    Cancer Immunol Immunother; 2020 Dec; 69(12):2501-2512. PubMed ID: 32561966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo.
    Deronic A; Nilsson A; Thagesson M; Werchau D; Enell Smith K; Ellmark P
    Cancer Immunol Immunother; 2021 Dec; 70(12):3629-3642. PubMed ID: 33948686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-inorganic hybrid nanovaccine for cancer immunotherapy.
    Zhu G; Liu Y; Yang X; Kim YH; Zhang H; Jia R; Liao HS; Jin A; Lin J; Aronova M; Leapman R; Nie Z; Niu G; Chen X
    Nanoscale; 2016 Mar; 8(12):6684-92. PubMed ID: 26947116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.